Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-11-19-Speech-3-327"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20081119.21.3-327"2
lpv:hasSubsequent
lpv:speaker
lpv:spoken text
"− This is certainly a difficult and complex area. The debate on cloning at the Commission refers to the use of a technology called somatic cell nucleus transfer (SCNT) with particular reference to farm animal breeding and how to deal with food produced from these cloned animals and their offspring. In the case of the use of this cloning technique in livestock reproduction and breeding in the agrofood sector, the questions are, in particular, related to animal health and welfare. In the case of the safety of food derived from cloned animals and their offspring, the questions are, in particular, related to any possible risk to human health and to the consumer’s right to be informed. The debate does not cover the use of SCNT in research. The Commission has been following the development of SCNT since 1996, when the first cloned mammal, Dolly the sheep, was born. In 1997, the Commission asked the Group of Advisers on the Ethical Implications of Biotechnology to issue an opinion on the ethics of cloning. In 2004, the Commission financed the project ‘Cloning in public’ under the sixth Framework Programme. This allowed an EU-wide debate to be launched as a first opportunity to have preliminary discussions with academics and civil society on ethical, legal and other societal aspects of farm animal cloning. The study concluded that the public is not well informed about the use and implications of cloning. The JRC published a study in 2007 in on the prospects for future commercial use of cloning technology. The study mapped the state of the art of the commercial applications of animal cloning worldwide and produced a pipeline of products and their estimated time of arrival on the market. The conclusion was that cloned animals were not expected to arrive on the EU market before 2010 and that reproductive materials – semen – from cloned animals may be the first products to be traded. Over recent years, the Commission has received information that the technology of somatic cell nuclear transfer for the reproduction of farm animals is about to reach its commercial stage, in particular, in third countries, notably the USA. Based on the final risk assessment, a report written by the US Food and Drug Administration scientists and issued in January 2008 concluded that the consumption of food from cloned animals and their offspring is safe as long as the food comes from healthy animals, which is a general principle in food safety. Only healthy animals enter the food chain. In order to prepare for an informed political debate, in 2007, the Commission asked the European Food Safety Authority (EFSA) to assess the actual and potential risks associated with the use of this technology in food production and also asked the European Group of Ethics (EGE) to issue an opinion on the ethical aspects of animal cloning for food supply. The Group released their opinion in January 2008 and the Authority in July 2008. According to EFSA, ‘based on current knowledge ... there is no indication that differences exist in terms of food safety between food products [derived] from healthy [animal] clones and their progeny, compared with those from healthy conventionally-bred animals’. Concerning the general health conditions of clones, the EFSA opinion states that there is no indication of adverse effects for the sexually reproduced progeny of cattle or pig clones. However, clones and their progeny have not yet been studied throughout the whole of their natural life span. At present, the EGE does not see convincing arguments to justify the production of food from clones and their offspring. The Commission also asked for a Eurobarometer survey to be carried out on the attitude of Europeans towards animal cloning. The results were made available in October 2008. The study showed that 58% of the respondents were against cloning for food production purposes. The Commission is now carefully considering these various elements to prepare an informal political debate on the use of somatic cell nucleus transfer for the reproduction of farm animals and food production. Should it be considered necessary to further develop the regulatory framework, it is important to recall that the new provisions would, of course, have to comply with the EC Treaty and with World Trade Organisation rules."@en1
lpv:unclassifiedMetadata
"Nature Biotechnology"1
lpv:videoURI

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz

The resource appears as object in 2 triples

Context graph